Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 19/20 | 0.61 |
| ▸ | MTOR | P42345 | 18/20 | 0.61 |
| ▸ | PIK3CA | P42336 | 17/20 | 0.61 |
| ▸ | ATR | Q13535 | 2/20 | 0.47 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.45 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.45 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.45 |
| ▸ | PRKDC | P78527 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17241779 | 0.96 | ATM (0.62) | ATMMTORPIK3CAATRKCNH2 | |
| SCHEMBL17241494 | 0.96 | ATM (0.62) | ATMMTORPIK3CAATRKCNH2 | |
| SCHEMBL17241449 | 0.96 | ATM (0.62) | ATMMTORPIK3CAATRPIK3CD | |
| SCHEMBL17241474 | 0.94 | ATM (0.61) | ATMMTORPIK3CAATRPIK3CD | |
| SCHEMBL17241472 | 0.91 | ATM (0.60) | ATMMTORPIK3CAATRPIK3CD | |
| SCHEMBL17241434 | 0.88 | ATM (0.60) | ATMMTORPIK3CAATRPIK3CD | |
| SCHEMBL17241457 | 0.86 | ATM (0.62) | ATMMTORPIK3CAKCNH2 | |
| SCHEMBL17241726 | 0.84 | ATM (0.61) | ATMMTORPIK3CAATRPIK3CD | |
| SCHEMBL17241432 | 0.84 | ATM (0.61) | ATMMTORPIK3CAATRPIK3CD | |
| SCHEMBL18824924 | 0.82 | ATM (0.59) | ATMMTORPIK3CAATRPIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3140303-A1 | IMIDAZO[4,5-C]QUINOLIN-2-ONE COMPOUNDS AND THEIR USE IN TREATING CANCER | Astrazeneca AB (SE) | 2017-03-15 | — | — | EP | claimed |
| WO-2015170081-A1 | IMIDAZO[4,5-C]QUINOLIN-2-ONE COMPOUNDS AND THEIR USE IN TREATING CANCER | ASTRAZENECA AB (SE) | 2015-11-12 | — | — | WO | claimed |
| EP-3140303-A1 | IMIDAZO[4,5-C]QUINOLIN-2-ONE COMPOUNDS AND THEIR USE IN TREATING CANCER | Astrazeneca AB (SE) | 2017-03-15 | — | — | EP | disclosed |
| WO-2015170081-A1 | IMIDAZO[4,5-C]QUINOLIN-2-ONE COMPOUNDS AND THEIR USE IN TREATING CANCER | ASTRAZENECA AB (SE) | 2015-11-12 | — | — | WO | disclosed |